{
  "entity_id": "B-004191",
  "folder": "Health-Ministers-Meeting-Forum",
  "name": "Health Ministers' Meeting Forum",
  "type": "Ministerial Council",
  "jurisdiction": "Commonwealth",
  "portfolio": "Health, Disability and Ageing",
  "website": "https://www.health.gov.au/committees-and-groups/health-ministers-meeting-hmm#:~:text=The%20Health%20Ministers%20Meeting%20(HMM,Australian%20Government%20Minister%20for%20Health.",
  "data_status": "partial",
  "completeness": {
    "has_strategy_brief": false,
    "has_strategy_structured": true,
    "has_vision": false,
    "has_kpi_targets": false,
    "has_kpi_results": false,
    "has_strategy_overview": true,
    "has_legislation_text": true,
    "has_legislation_structured": false,
    "has_global_initiatives_text": false,
    "has_ideas": true,
    "has_artifacts": true,
    "n_ideas": 12,
    "n_legislation": 0,
    "n_artifacts": 4,
    "n_kpi_targets": 0,
    "n_kpi_results": 0,
    "n_outcomes": 0,
    "verified_own_data": true
  },
  "strategy_profile": {
    "status": "needs_review",
    "confidence": "medium",
    "summary": "",
    "official_site_url": "https://www.health.gov.au/committees-and-groups/health-ministers-meeting-hmm#:~:text=The%20Health%20Ministers%20Meeting%20(HMM,Australian%20Government%20Minister%20for%20Health.",
    "source_documents": [
      {
        "type": "strategie",
        "title": "Framework for the assessment, funding and implementation of high cost, highly specialised therapies and services [PDF - 2 MB] - 19 pages",
        "url": "https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf",
        "period": "2024",
        "confidence": "medium"
      },
      {
        "type": "strategie",
        "title": "Standard for AI transparency statements",
        "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf",
        "period": "2024",
        "confidence": "medium"
      }
    ],
    "purpose": null,
    "vision": null,
    "strategic_priorities": [],
    "values": [],
    "outcomes": [],
    "performance_measures": [],
    "document_alignment_terms": {
      "must_support": [],
      "watch_terms": [],
      "avoid_claiming_without_evidence": []
    },
    "review_note": "Structured strategy exists but is incomplete."
  },
  "strategy_brief_md": null,
  "strategy_overview_evidence_md": null,
  "internal_strategy_evidence_md": "# Health Ministers' Meeting Forum - Strategy, Performance, and Operating Profile\n\n**Generated at**: 2026-05-09T22:38:46.591578+00:00\n**Entity ID**: B-004191\n**Entity type**: Ministerial Council\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n**Website**: https://www.health.gov.au/committees-and-groups/health-ministers-meeting-hmm#:~:text=The%20Health%20Ministers%20Meeting%20(HMM,Australian%20Government%20Minister%20for%20Health.\n\n> Draft generated from scraped source material. Treat this as an evidence pack for editorial review, not a final judgement.\n\n## Source Coverage\n\n| Source type | Count |\n|---|---:|\n| other-pdfs | 1 |\n| pages | 23 |\n| reviews | 1 |\n| strategies | 2 |\n\n## Executive Readout\n\n### Purpose\n\n- Other complaints avenues\nUnder Australian Consumer Law, ART providers are required to comply with obligations\naround guarantees of service quality, prohibition of misleading or deceptive conduct, and\ncontracts and refunds.123 Consumers can file a complaint with their jurisdictional consumer\nprotection agency if they believe an ART provider has breached its statutory guarantees, such\nas failing to provide the service with due care and skill, or providing gametes that are not fit\nfor purpose.124 Additionally, the Therapeutic Goods Association can investigate complaints\nabout misleading or inappropriate advertising of therapeutic goods directed at consumers\n(including false or exaggerated health claims).125 The Australian Competition and Consumer\nCommission (ACCC) also takes reports from people about possible issues under consumer\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- However, there are also practical and\nlegal dimensions to this approach that would\nMinisters have sought consideration of an additional\nneed to be fully examined, to avoid unintended\nMinisterial Power of Policy Direction for accreditation\nconsequences and to establish whether it would\nfunctions and progressing introduction of such a\nachieve the desired outcomes.\npower has been recommended in the Scope of\nPractice Review.16 • In the context of concerns about accreditation\ndecision making at specialist medical training sites,\nThe potential of this extended power is recognised.\nsteps to implement recommendation 13 from\nHowever, in the context of the complex dispersed\nthe NHPO inquiry (requiring a communications\narrangements for delivery of accreditation in the\nprotocol to ensure effective routine management of\nNational Scheme (as between the National Boards,\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- [Page 7]\nEXECUTIVE SUMMARY\nThe Review approach\nThe overarching objective of this Review was to identify During this final phase of targeted consultation:\nareas of unproductive and unnecessary complexity\n• 37 policy design forums were conducted,\nwithin the National Scheme.3\ninvolving 83 organisations, with more than 250\nIt has strived for greater clarity about what is needed individuals participating.\nfrom health practitioner regulation (noting that this\n• 36 written submissions and comments\nwill change over time).\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- [Page 22]\nFINAL REPORT TRANSFORMING HEALTH PROFESSIONS REGULATION IN AUSTRALIA\n• Consideration of model regulatory powers and Taking such strategic opportunities and realising\noutcomes that could apply to all these settings. these benefits requires a collaborative arrangement,\nideally building upon the current informally constituted\n• Information sharing protocols for high risk\nAustralian Health Regulators Network (the Network),\nindividuals and organisations – this element\nwith the objective of adding breadth, structure and\nwould relate to the other recommendations in\nimpact to its deliberations.\nthis Report for cooperative regulation (including\nthe recommendations for improved information In terms of the composition of this Network, its current\nsharing between Commonwealth and jurisdictional informality results in relatively fluid engagement and\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n\n### Role and Functions\n\n- [Page 39]\napproximately 150 employees (albeit to deliver a far greater span of responsibility) and is\nfunded jointly by the Australian Government and by State and Territory governments.137\nThe FSANZ-sponsored Framework for an Australian 10-Year Fertility Roadmap found that\nRTAC is not sufficiently resourced to allow for more comprehensive review functions,\nrecommending reform to its funding model (Recommendation 10).138 The 2024 Queensland\ninvestigation of ART providers also noted that the capacity of RTAC to undertake review of\nincidents may be constrained by a lack of resources.139\nMany stakeholders expressed concern that, while it has done well with the resources\navailable, RTAC is not adequately resourced to effectively perform the accreditation functions\nexpected of it, especially given the growth in and complexity of Australia’s ART sector.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- [pages 17,18,19]\nra’s NRAS, the ART sector relies on other\nmechanisms to ensure quality and safety:\n• The Code of Practice requires ART units to ensure that all staff are authorised to perform\nthe functions they have been employed to carry out,57 with specific qualification, training,\neducation, and experience requirements for several key personnel.58 As with other Code of\n56 For example, Queensland, South Australia and Victoria have a limit of 10 donor related families, while\nAustralian Capital Territory, New South Wales, and Western Australia have a five-family limit.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- The standards regulation – particularly to maintain\nkey requirements to be a high performing, risk-based strength in clinical advice, investigation and\nregulator can be identified across the two key domains prosecution capabilities and regulatory intelligence.\nof organisational and regulatory enablers, as follows.14\n• An embedded and enduring ethos of working in\ncollaboration with professions, peak bodies, State\nORGANISATIONAL ENABLERS\nand Territory jurisdictional health regulators and\n• Clear purpose and clarity of role other national health regulators.\n• Strategic and visible leadership, appropriate • Continuous improvement and a learning culture.\nsupporting structure and culture\n• Good internal governance\nAN IMMEDIATE STRATEGIC AGENDA\n• Accountability and transparency FOR THE NATIONAL SCHEME BOARD\n• Capable people\nThe Ministerial Council Statement of\n• ICT and data systems\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- It is also a requirement of the Code of Practice that all staff are authorised to perform the\nfunctions they have been employed to carry out,49 with specific qualification, training,\neducation and experience requirements for several key personnel, including professions that\nare not covered under the National Registration and Accreditation Scheme (NRAS) such as\nlaboratory managers, counsellors and quality managers.50 This includes a requirement for\nMedical and Clinical Directors to have a Certificate of Reproductive Endocrinology and\n42 Fertility Society of Australia and New Zealand, RTAC Scheme – Requirements for bodies providing audit and\ncertification to the Code of Practice for Assisted Reproductive Technology Units (20 December 2021) (‘RTAC\nScheme Rules’).\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- ACTION 1.2 1.2.3 Disband the Jurisdictional Advisory Committee\nand its Jurisdictional Lead Officials Committee,\nConfirm the HWT as an ongoing Advisory\nto be replaced by a Health Practitioner\nCommittee to Health Ministers with the primary\nRegulation Committee of HWT.\nrole of advancing national workforce projects and\ninitiatives, including overseeing and contributing\nto processes for aligning workforce planning and ACTION 1.3\nhealth practitioner regulation, in collaboration\nHealth Chief Executives Forum (HCEF) to\nwith relevant professional bodies.\nconsider the option of a Strategy Assembly on\n1.2.1 Revise HWT Terms of Reference and Health Workforce and Practitioner Regulation\nrepresentation, to include: to be held every two years.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- [pages 69,70,71,72]\nthe Independent Accreditation\nabout the role of the Ahpra Board Committee (IAC) as the entity to oversee and\nrelative to National Boards, a strategic guide delivery of accreditation reforms within\napproach to the cycles and sequence the Scheme.\nof review, identification of issues to be\n3.5.2 Ahpra Board to set immediate priorities and\naddressed across professions, clearer\ntimeframes for the IAC work program, which\nprotocols and practices for stakeholder\nshould include:\nengagement, and arrangements for\nadvice to Ministers. a.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n\n### Strategic Priorities\n\n- Scheme wide priorities 2025-26 — Built into the National Scheme Strategy 2025-30\n• Capability Review of Ahpra • Focus on accreditation • Reset National Board selection\naccountability reforms criteria and processes\n• Develop Scheme-wide performance\nmonitoring and reporting framework • Establish clear processes for • Strengthen stakeholder\nreview and approval of Codes engagement practices\n• Review budget and fee setting\nand Standards (including channels\nprocesses – transparent principles\nfor advice to Ministers)\nfor use of registrant funds\n64\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- Available at: https://\n3 Terms of Reference for the Review available www.health.gov.au/sites/default/files/2024-11/\nat: https://www.health.gov.au/sites/default/ unleashing-the-potential-of-our-health-workforce-\nfiles/2024-06/independent-review-of-complexity- scope-of-practice-review-final-report_0.pdf.\nin-the-national-registration-and-accreditation- p129 suggested seven indicative priority self-\nscheme-terms-of-reference.docx regulated professions -dieticians, Sonographers,\nAudiologists, Exercise physiologists, Speech\npathologists, Social workers and Counsellors.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- Ahpra Board to pursue immediate strategic priorities\nidentified in this Review through its current cycle\nof review of the National Scheme Strategy (2025-\n30) and present the revised Strategy to HWT and\nMinisters within 6 months, with a report to Ministers on\nimplementation of the Scheme Strategy in each future\nQuarterly Performance Report.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- [pages 69,70,71,72]\nthe Independent Accreditation\nabout the role of the Ahpra Board Committee (IAC) as the entity to oversee and\nrelative to National Boards, a strategic guide delivery of accreditation reforms within\napproach to the cycles and sequence the Scheme.\nof review, identification of issues to be\n3.5.2 Ahpra Board to set immediate priorities and\naddressed across professions, clearer\ntimeframes for the IAC work program, which\nprotocols and practices for stakeholder\nshould include:\nengagement, and arrangements for\nadvice to Ministers. a.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- This\nof national complaint handling explanatory\nlinks to action 3.3.\ninformation as an immediate priority, to\ncommunicate the Integrated Health Professions 4.3.2 Immediate interim actions to improve\nRegulation Framework (links to action 2.1) investigation governance should also be\nand present a joint message on proposed progressed and include:\nreforms to complaints handling, setting out\na.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- [Page 25]\nTHEME 1: SETTING STRATEGIC CONTEXT, PRIORITIES AND ACCOUNTABILITY FOR\nHEALTH PROFESSIONS REGULATION AND THE NATIONAL SCHEME\n1.3.2 The Strategy Assembly could receive:\nACTION 1.5\na.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- Leadership structures and culture:\nAhpra Board to pursue immediate strategic\nStructure matching strategy; clear\npriorities identified in this Review through its\ndelegations; effective connection between\ncurrent cycle of review of the National Scheme\nState offices; strong relationships and\nStrategy (2025-30) and present the revised\ntimely and objective advice to Ministers and\nStrategy to HWT and Ministers within 6 months,\nboards; risk management; performance\nwith a report to Ministers on implementation of\nreporting and accountability tools and\nthe Scheme Strategy in each future Quarterly\nprocesses; communication.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- [pages 17,18,19]\nra’s NRAS, the ART sector relies on other\nmechanisms to ensure quality and safety:\n• The Code of Practice requires ART units to ensure that all staff are authorised to perform\nthe functions they have been employed to carry out,57 with specific qualification, training,\neducation, and experience requirements for several key personnel.58 As with other Code of\n56 For example, Queensland, South Australia and Victoria have a limit of 10 donor related families, while\nAustralian Capital Territory, New South Wales, and Western Australia have a five-family limit.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n\n## KPIs, Targets, and Where They Are At\n\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- [pages 17,18,19]\nra’s NRAS, the ART sector relies on other\nmechanisms to ensure quality and safety:\n• The Code of Practice requires ART units to ensure that all staff are authorised to perform\nthe functions they have been employed to carry out,57 with specific qualification, training,\neducation, and experience requirements for several key personnel.58 As with other Code of\n56 For example, Queensland, South Australia and Victoria have a limit of 10 donor related families, while\nAustralian Capital Territory, New South Wales, and Western Australia have a five-family limit.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Other complaints avenues\nUnder Australian Consumer Law, ART providers are required to comply with obligations\naround guarantees of service quality, prohibition of misleading or deceptive conduct, and\ncontracts and refunds.123 Consumers can file a complaint with their jurisdictional consumer\nprotection agency if they believe an ART provider has breached its statutory guarantees, such\nas failing to provide the service with due care and skill, or providing gametes that are not fit\nfor purpose.124 Additionally, the Therapeutic Goods Association can investigate complaints\nabout misleading or inappropriate advertising of therapeutic goods directed at consumers\n(including false or exaggerated health claims).125 The Australian Competition and Consumer\nCommission (ACCC) also takes reports from people about possible issues under consumer\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Ensuring the quality\nand safety of protocols used by overseas gamete banks is also more difficult for local ART\nproviders, as is evident from the recently reported case of a mis-identified sperm donor.174\n172 For example, the risk of consanguineous relationships is higher in smaller jurisdictions: Sonia Allan, The\nReview of the Western Australian Human Reproductive Technology Act 1991 and the Surrogacy Act 2008:\nReport Part 1 (Report, January 2019) 119–28.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Scheme wide priorities 2025-26 — Built into the National Scheme Strategy 2025-30\n• Capability Review of Ahpra • Focus on accreditation • Reset National Board selection\naccountability reforms criteria and processes\n• Develop Scheme-wide performance\nmonitoring and reporting framework • Establish clear processes for • Strengthen stakeholder\nreview and approval of Codes engagement practices\n• Review budget and fee setting\nand Standards (including channels\nprocesses – transparent principles\nfor advice to Ministers)\nfor use of registrant funds\n64\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- There\n– A requirement that all decisions that would\nshould be clearer recourse for practitioners\nresult in extending the period that an\ninvestigation is open beyond 12 months be where there is potentially unnecessary\ndecisions of the Board, not regulatory officers.\ndelay in progressing matters to a tribunal,\n– An obligation on regulatory officers and the particularly where a practitioner has already\nBoards to consider the personal and financial\nbeen suspended through immediate\nimpacts on a practitioner in any decision to\naction powers.\nplace and investigation ‘on hold’.\n• Use the tagging and alert functions of the new\nThe Review was particularly struck by the strength of\nAhpra case management system to implement a\njudicial commentary on this specific issue in Peers v\nsystem for identifying, monitoring and reporting on Medical Board of Australia.27\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- Available at: https://\n3 Terms of Reference for the Review available www.health.gov.au/sites/default/files/2024-11/\nat: https://www.health.gov.au/sites/default/ unleashing-the-potential-of-our-health-workforce-\nfiles/2024-06/independent-review-of-complexity- scope-of-practice-review-final-report_0.pdf.\nin-the-national-registration-and-accreditation- p129 suggested seven indicative priority self-\nscheme-terms-of-reference.docx regulated professions -dieticians, Sonographers,\nAudiologists, Exercise physiologists, Speech\npathologists, Social workers and Counsellors.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- It is also a requirement of the Code of Practice that all staff are authorised to perform the\nfunctions they have been employed to carry out,49 with specific qualification, training,\neducation and experience requirements for several key personnel, including professions that\nare not covered under the National Registration and Accreditation Scheme (NRAS) such as\nlaboratory managers, counsellors and quality managers.50 This includes a requirement for\nMedical and Clinical Directors to have a Certificate of Reproductive Endocrinology and\n42 Fertility Society of Australia and New Zealand, RTAC Scheme – Requirements for bodies providing audit and\ncertification to the Code of Practice for Assisted Reproductive Technology Units (20 December 2021) (‘RTAC\nScheme Rules’).\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- The ANZARD report shows that there is significant variation\nin success rates between the best performing and worst-performing clinics in Australia, with\none measure ranging from 4% to 35% success.99\nTable 2.3: Clinics reporting on YourIVFSuccess.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- While there are some sound policy rationales as to why jurisdictional restrictions differ,172 this\nvariability may ultimately result in ‘jurisdiction shopping’ by prospective parents, undermining\nthe original policy intent.173 Several stakeholders reported that donor limits and inconsistencies\nin those limits lead people to look outside the regulated system, to ‘informal’ donor\narrangements such as those arranged through Facebook groups or other unregulated\nenvironments.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- [pages 1,2,3,4,5,6]\n[Page 1]\nStandard for AI\ntransparency\nstatements\nSupporting the policy for responsible\nuse of AI in government\nUse the following\ninformation to support\nyour agency’s\nimplementation of the\npolicy for responsible use\nof AI in government.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n- [pages 1,2,3,4,5]\n[Page 1]\nFramework for the\nassessment, funding and\nimplementation of high cost,\nhighly specialised therapies\nand services\nApril 2024\nHealth Ministers’ Meeting\n  Source: `strategies/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-spec.pdf (https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf)`\n- [Page 3]\nContents\nAbbreviations 2\nIntroduction 3\nPre-application information sharing 5\nAssignment of HTA assessment committee 6\nHTA committee assessment and decision making 9\nNational implementation and coordination of HSTs 11\nMonitoring and Evaluation 14\nAppendix A 16\nFramework for the assessment, funding and implementation of high cost, highly specialised therapies and services 1\n  Source: `strategies/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-spec.pdf (https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf)`\n\n## Key Metrics\n\n| Values found | Evidence | Source |\n|---|---|---|\n| $59.2 billion, 59.2 billion | In 2021-22, $59.2 billion in Commonwealth, state and territory funding was administered under the NHRA. | `pages/homepage.html (https://www.health.gov.au/committees-and-groups/health-ministers-meeting-hmm#:~:text=The%20Health%20Ministers%20Meeting%20(HMM,Australian%20Government%20Minister%20for%20Health.)` |\n| $23 million, 23 million | Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n| $6,711.65, $2,615.50 , $834.50 | For example, IVF Australia, a member of\nVirtus Health, projects the out-of-pocket costs for patients for an initial IVF cycle as of 1st June\n2025 at $6,711.65.33 Once annual out-of-pocket medical expenses exceed the Extended\nMedicare Safety Net (EMSN) threshold of $2,615.50 for general patients or $834.50 for\nconcessional patients, Medicare provides an additional rebate of 80% of the out-of-pocket cost\nor the EMSN cap for the item, whichever is l | `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)` |\n| $74 million, 74 million | Have your say on the aged care reforms\n23 March 2026\nNews\nThe Aged Care Reform Sector Pulse Survey is your opportunity to share your feedback about the implementation of the aged care reforms.\n$74 million to drive genomic health research\n19 March 2026\nNews\nRead about the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n| $36 billion, $810 million, 36 billion, 810 million | [Page 67]\nlegislative reform, intergovernmental negotiation and system redesign.199 While some\nstakeholders cited examples of standalone regulators, such as the Aged Care Commission, aged\ncare is a $36 billion industry compared to the much smaller $810 million ART sector.200\nRecommendation\nBoth options provide consistent registration and reporting requirements. | `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)` |\n| 80% | Care Quality and Safety Commission, at p 28\ngov.au/Publications/Annual-reports/Annual-\navailable at: https://www.health.gov.au/resources/\nreport-2024.aspx#:~:text=The%20Australian%20\npublications/final-report-independent-capability-\nHealth%20Practitioner%20Regulation%20\nreview-of-the-aged-care-quality-and-safety-\nAgency%20and%20the,report%20is%20\ncommission?language=en.\n%E2%80%98Leadership%20and%20\n15 See for instance Submission 17 – Australasian | `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)` |\n| $100 | Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission. | `pages/about.html (https://www.health.gov.au/topics/about-the-department)` |\n| $6 | HČĒĖňģř4\u0014ÖÁ~äż\u0002ŲĪ∑ÔSz(\u0013*ĶĘ\u0012c\u0014ŕ\"Ů\u001fPŘ\u0001āßgm{;…Ď(ď$vb{eŪŚ/yz{ýeŻūŽŘÁ◊ŰŰśēßÔě_ĎýllHŃ5Ŗ®\u0006úK$n…Eőz.ŰŚÉýôĢ0ř•“»ďw≠Vú7O?Łšť”WůôāŰň—Ö‘\u0002ĶP\\≠Ī”Ųbš∆čiéc#čē\\|Mt1›Ö\u001c–őģpĘ‚ō3ŔžĚŌLŃē<[Ĺ$ŕĆMőųą\u000evú0Iw©\u0017ĆŇ\u001a\nŌ]OĹôŖŐGůÓ§©Ļō\nű».•ė\u000fIŲVďÖÍT\u000bn uŇįN…ŚLp\bc1QĮcyŰŹ√ź\u0016R&\u0018\u0017jĄpőć≤ęĺéĶ∑©\u0004ŽĹŖ–\\|ˇó\u001cĺRū8ż#◊_pÝ$6\u0006Ī\u0011\u001d?>Ĺ~ŮŰŁÁ7\u000e„”į0áŃ4xš]\n\u001dGÓ,5ŠÜjĚ\u001dŮ\u0019™[Lģ∑\u0018\u000fKłĽ\"÷¬ķP\nlÄi>Vtŗ=ô\"¶ŚéVwĆ™Ī\u0014\u0019ÓĒŗrĀĪÜYě≤\u0005n1‹Ä\u0011RG‹ģĻíx\bõm\u0016ď√É:Y\fÁ\b©]dD\u0004b◊u3V ď!A&w—g≠WFv-Ľ(ŃB)\u0019ēc,ćq\u00013ųé Ý.:mu%\u0015™ģč>T\ny∆\\|≠ú™\u0006\u0007\"ŕģCźš | `pages/reviews-index__07.html (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)` |\n| $5 | HČĒĒMé‘0\u0010Öų9Ö/ŗ¬ģ\u001fˇúÄűą\u0005\u0007\u0018\u0001\u000bfźÄŻK<ßúń› —≠H›iĽďWĮ>ŅķĻēJY$DģLR{–ĘĒĖÔ__∂ŌŠ«ĖHJ\u000eČłŪüēC\nŖ∑\u000f\u001f?•ūŪųŲ3`\u0015W\u000eíĆŐ™Ą‹ĒDĻÖ◊ųmlĹoĪPe(A1)á∑-f!’āMŅÔ≠ĄN-)\u0014LŕłŌeÔŽŲu{A\nZŕÝM≠÷]ˇ“Ś‹)Ķģ!óN•IĺtĪ£j–U≤žļL \u001cĘQ∆∆X(T™\u0005°\nŮ(ńūŕŠ“Vűŗ◊™öUQ£@ē\u0005¶zĹTē©XÜ\u0006S∂>D:YÍa~Ļh\u001bż`Í÷P\u001eYŠPI8Ŗxőā\u001ePG'GÁ\u0013\n^+Ť†$5X&”lóľu+ūí©ē:š‹žŠ}Ť+i\u001eűš\u001ab√Ŗ$(Ī…ćķŅ®_Í\u0015ĮŤ Ň\u000bŤôÍ•?!OśoX=hÔĚ\u0018ź\u001dy\u001b\u0015žúwśŹ—n(ŕí\f7iōYÖĚÚĄĢ∂że{Bě»£cěŐˇC[Ćj\u001bŌĘŽeú÷ę›Nyá>žřĪěą\u000f‚\u000ey\u0012ú5ßJ‹3^ńj§Uó„69OžoŘż\u0011w ;r¨:Á żq‹‹\u0019\nņPą\\Ć\u0012/!sőgīód/ĒGŖ\u001ds\\|&Ř\u0018K®\u0017áô | `pages/reviews-index__07.html (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)` |\n| $6 | HČĒĒMé\u00141\fÖų9E.\u0010\u0013;őŖ XŹXpÄ\u0011įė\u001e§ĀŻKľ$ģT5 ėVI›U©n?ŘüüŖ\\/ń©ķ ö(’ž5\u0016ä5ŪÔ\u001f_‹gˇ›EŁ™ÝH]ög\\|GÕĢŇ}ÝÝ)ķo?›Ř8√Ň^*S…Ö=g°řcůŌĮnľzuBMõ\u000f•RÖŗÕ\u0005Ó‘ĘÝź®%\u001d\u0007ĘńQ=3Ī®\u000fąĄ0§]fūgų’=!ĎTF\u0002“śg\u001dÔ^. pÔTKŃ?\u0005B™zI†Qő \u00190bÚŐ†Pď\f•°83(ĒQ\u0019S\u001c Tt\u0004\u0011\u0013’XÓR–“∆3ĶZóG\u001b#«žk!T_NuŪ8Ť>h¶÷ÚTg\u0012\u001c Č …ÍÔł\u000bĚxú\u000bąGď\u0012_’żļÓT\u0019D§5ŖH$Ěö%Q)\b% J≥b•ėFkGďō š\bMģņÖ9`šÄ_(i™w5ˇćˇ%Éą≤T šŘrĺ\u0014nņ\u0017Ģõ[ī\u000fÝę\n\u0013∑—\u000fÜ\\|‚Ä{\u0002īÜ\"\u0003'\u0014ßý\u0002řÄ\u001bˇõ[ł\u000fķ#ÖŇŘŤ\u0007#nŁŖ ĺ1ö3\u0006úa©\u001c!pĘ_»m\u0002†ŅąŘ‹‹‚}“\u001fņ\u0017ĢŁ\u001fūí#ēŔ5ĎNŕ\u0010Ó\u001cų\u0005›f™čĻćě\u000f‚6\u0001\u000bý1ÔGü–∂“z\u001ac6ĶÝŐ!,ÍŘůď:Ģ | `pages/reviews-index__07.html (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)` |\n| $3 | 4 \u00123\u0005x…ŖeŔĖ\u001dŮ\u001d]ĮV aė\u0018Ģ‘ķLśĒ\u0003ŌXŹZÔŻú‹vÉ\u0001§JĒ*ę¨hŪY\u000fÉě\\|\u0015%ŅUm ĺÔů\u001cŇ)T]“†\u0001ÁrÜ\u001cĮŇĽL\u000bńś3•k$\u0007Ó>Řdi4*zď„ćźŃěĘęőŻ{ūE\f}Ē7Łā\u0019RĪS°R$3\u0015hĢ Ä®4@,íDĪšBňS5\u0018\u000eďV\u001eŌŔ\u0007©SőěJiļū\u001b\u0012éŤŪĒgĮ}Ž\nńĚ≥ľm(ĚŹĻF\u000b_Ĺžžė\n\u0006جsić&r#ĚÓtćűī^≥y◊}ˇWŰ\f\u0014L‚ś\u0007~u£\"I‚(řnónTŁN`ľ \u0010T©‘°&M,ĺ/āfįiģ\bŌ~\u0003Kę‚M8\u0004Ź\u0007’@ ÖfVľ›ņĎ•udĢ…8řEb,≤2U÷\u0005ÄŚX;ń\u0004íĒ…īu\n*\u0007\u0019(x#Ĺ\u000e™ŗśĻ\u000b\nżŽiW\bčcě™÷įčŪ  ŤK\u0005ł…íļĄ„}YżU8°\u0003`ĺļ:£\u001f\u0016—bĀl\\ō\bĶJ:ęFĖnp)–āż_ń\u000eĺ%ŇĽű\u000eŪ◊X,\\|\u0010oHŁe\u0013≥#=ŰŐJ\u0005∆Īł nre,w¶úÜWąHá\u001ah0ď=ôő\u000f썅IKp\u0003Ĺ—•ň›ÄŻoM\u001f\"?ÔŘŹ∂£^oq,ūnA@š†ĖÉ< | `pages/reviews-index__07.html (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)` |\n| $5 | Gě®,kkŖ–D<÷c\u0005ūáÝĒē’ŌvÄNŁDYÚ\u0016\u0011ŖĄ4…h«z\u0017 Oeēň7ô∑įpĮ}\u0002\u0018Ľú’- ›BW•ŇēÜȨ\bĪ0ý\u0003v$5Ě»=\u0011$õh\u0007,¨įĎ,VěN;\bZ^∂s™#Įādúß9\u0014ťÜÁsó.á∂i 4Mš—∂A\u0016żķÚe\u0010\u001bŤÍ∆•ďĆű-Ł+ŅĆ\u0005 \u001eAżű)į\u0015į≥ zuEŔŃ\u000bmźŲ\u0005•∆/\u001a‹č>ÖQy?\u0015'#–&ų\u0001OŖ◊Ű>ˇô«ňňŁ6DIÝR◊āōÉŚĹęˇň”ůXbē ČBÔZÜa–“∆uÁįŹ'4£l\u0007\u0010r']\u001f–s√!\u001ežw ∑Ro~ A\u0015◊—zĻs\u0004ÓŅ.∑ę(^ń[∂JĖab\u0017ŕyL/\u000f©~Ļ›b-ČŮ÷\"ŕŰŽ \u0015īÔ›Ģ\u000biŚS+ĚěŃŁŐ$\u0006ÄŲ\u001aÝ\u0003†\u000e;ų\u001d#1=/7KyNāSĪ1¨ąZďEí<Ä7ä√\u001b^™∂2É{Ěcv\u001fŽiřt\nŚŗÔň\u0011T◊sˇGp\u0004A&∑;Č\u001fdģ¶d•ę“É$Įvę(Y'+∂‹mĘeóšdúš’nčĹ\u0012\u001e.wň~ úŘŲŻ@Żťv3$ÍüĪlXUéÄů.KÉř¶p¶eė4ů‹é§Ż$\fmJ`\u0014 | `pages/reviews-index__07.html (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)` |\n\n## Key Achievements\n\n- In 2023, 81% of ART cycles were provided\nto male-female couples, 14.6% were to single women, and 4.4% were to female-female\ncouples.9 For oocyte and embryo recipient cycles, almost 40% were provided to single women\nor female-female couples, indicating growing inclusivity in access to fertility services.10 This is\nalso reflected in a growing demand for donor gametes that exceeds supply.11 This has resulted\nin increased importation of gametes from international gamete banks and the increased use\nof informal channels by consumers for gamete donations.12\nART services are predominantly delivered by private providers\nThe number of ART providers and ART clinics in Australia continues to grow.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Four large ART providers currently account for about 80% of the Australian market share:\nVirtus Health (37%), Monash IVF (31%), Genea (12%), and City Fertility Centre (5%).17 The\nemergence of these four providers reflects a progressive consolidation of the ART sector, with\nthe major providers expanding their market share through mergers and acquisitions.18 It is\nlikely that the trend for consolidation will continue with the larger companies pursuing further\nclinic acquisitions.19\nART services are delivered in all states and territories.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- [Page 34]\nFINAL REPORT TRANSFORMING HEALTH PROFESSIONS REGULATION IN AUSTRALIA\nFIGURE 2: RISK-BASED HEALTH PRACTITIONER REGULATION UNDER THE NATIONAL SCHEME\nPurpose of Risk Assessment Method • Distinguish between higher or lower risks\nRegulation — Actual or potential harm\n• Retain 2 staged assessment process\nEnsure public — Initial consideration of suitability — Factors that may amplify harm (e.g.\nconfidence that inherent nature of the services delivered,\nrisks posed by — Regulatory impact analysis – full or likely predominance of vulnerable patients,\nhealth occupations modified as required by Ministers. typical practice setting)\nwill be addressed • Revised initial suitability criteria and guidance — Any risk mitigation already in place (e.g.\neffectively and – wider definition of risk, earlier and clinical governance, peer support and\nproportionately.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- [pages 17,18,19]\nra’s NRAS, the ART sector relies on other\nmechanisms to ensure quality and safety:\n• The Code of Practice requires ART units to ensure that all staff are authorised to perform\nthe functions they have been employed to carry out,57 with specific qualification, training,\neducation, and experience requirements for several key personnel.58 As with other Code of\n56 For example, Queensland, South Australia and Victoria have a limit of 10 donor related families, while\nAustralian Capital Territory, New South Wales, and Western Australia have a five-family limit.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Other complaints avenues\nUnder Australian Consumer Law, ART providers are required to comply with obligations\naround guarantees of service quality, prohibition of misleading or deceptive conduct, and\ncontracts and refunds.123 Consumers can file a complaint with their jurisdictional consumer\nprotection agency if they believe an ART provider has breached its statutory guarantees, such\nas failing to provide the service with due care and skill, or providing gametes that are not fit\nfor purpose.124 Additionally, the Therapeutic Goods Association can investigate complaints\nabout misleading or inappropriate advertising of therapeutic goods directed at consumers\n(including false or exaggerated health claims).125 The Australian Competition and Consumer\nCommission (ACCC) also takes reports from people about possible issues under consumer\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Ensuring the quality\nand safety of protocols used by overseas gamete banks is also more difficult for local ART\nproviders, as is evident from the recently reported case of a mis-identified sperm donor.174\n172 For example, the risk of consanguineous relationships is higher in smaller jurisdictions: Sonia Allan, The\nReview of the Western Australian Human Reproductive Technology Act 1991 and the Surrogacy Act 2008:\nReport Part 1 (Report, January 2019) 119–28.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- The final advice will then be provided\nto the State and Territory representative to inform their The 2020-25 NHRA Addendum defines HSTs\ndiscussion at the Joint Chairs meeting. as: TGA approved medicines and biologicals\ndelivered in public hospitals where the therapy\nand its conditions of use are recommended by\nMSAC or PBAC; and the average annual treatment\ncost at the commencement of funding exceeds\n$200,000 per patient (including ancillary services)\nas determined by the MSAC or PBAC with\ninput from the IHACPA; and where the therapy\nis not otherwise funded through a Australian\nGovernment program or the costs of the therapy\nwould be appropriately funded through a\ncomponent of an existing pricing classification.\n  Source: `strategies/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-spec.pdf (https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf)`\n- [Page 11]\nEXECUTIVE SUMMARY\nDIRECTION 04\nProgress implementation of a unified national approach to\nhealth complaints and require immediate focus on improved\nmanagement of high-risk matters within the National Scheme,\nto ensure best practice complaint management.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- 2.5.1 HWT to request the National Complaints\n– Assembly of regulatory intelligence to\nHandling Implementation Group (proposed at\nsupport proactive regulation of non-\nAction 4.1 of Direction 04) to establish a cross\nregistered practitioners.\njurisdictional Working Group to develop and\nprogress a program of work to strengthen – Education of practitioners on standards\nthe effectiveness of the implementation of the and obligations.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- Scheme wide priorities 2025-26 — Built into the National Scheme Strategy 2025-30\n• Capability Review of Ahpra • Focus on accreditation • Reset National Board selection\naccountability reforms criteria and processes\n• Develop Scheme-wide performance\nmonitoring and reporting framework • Establish clear processes for • Strengthen stakeholder\nreview and approval of Codes engagement practices\n• Review budget and fee setting\nand Standards (including channels\nprocesses – transparent principles\nfor advice to Ministers)\nfor use of registrant funds\n64\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n\n## Key Issues, Risks, and Recommendations\n\n- Risk Assessment Process\nSTAGE 1\nStructured and transparent EOI process for suitability assessment\n2 yearly EOI cycle\nSpecified requirements for EOI documentation\nHWT established EOI Advisory Panel including independent expert advice\nPanel advises HWT\nHWT recommendation to Ministers\nMinisterial determination\nProfession notified of decision\nSTAGE 2\nRegulatory Impact Analysis to consider costs and benefits and level of\nany required regulation (full or modified impact analysis available)\nMinisterial Determination\nNo additional Profession-led regulation Ahpra National\nregulation required under potential new entry pathway Board Regulation\n32\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- It provides regular\nperformance benchmarking and feedback to ART units and RTAC.91 All ART units are required\nto provide de-identified patient and treatment information to ANZARD on IVF cycles, donor\ninsemination cycles, pregnancy and birth outcomes as well as demographic details including\nsex, age, and infertility diagnosis.92\nThese data are used to inform benchmarking of each ART unit against the publicly available\nannual ANZARD Report.93 If clinical outcomes (e.g. pregnancy rates) fall below the 25th\npercentile in an age group the ART unit must undertake a root cause analysis and address\nany issues during the audit process.94 If clinical outcomes fall below three standard\ndeviations,95 the RTAC Chair will notify the unit.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- [pages 28,29,30]\nnsider RTAC accreditation alongside a range\nof issues such as other statutory requirements, complaints management, and risk\nmanagement.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Other complaints avenues\nUnder Australian Consumer Law, ART providers are required to comply with obligations\naround guarantees of service quality, prohibition of misleading or deceptive conduct, and\ncontracts and refunds.123 Consumers can file a complaint with their jurisdictional consumer\nprotection agency if they believe an ART provider has breached its statutory guarantees, such\nas failing to provide the service with due care and skill, or providing gametes that are not fit\nfor purpose.124 Additionally, the Therapeutic Goods Association can investigate complaints\nabout misleading or inappropriate advertising of therapeutic goods directed at consumers\n(including false or exaggerated health claims).125 The Australian Competition and Consumer\nCommission (ACCC) also takes reports from people about possible issues under consumer\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Audit outcomes are provided\nto individual providers and to the RTAC Chair, but there is no mechanism to share lessons\nlearned or identify systemic risks.163 This lack of transparency and coordination was seen by\n159 Office of the Health Ombudsman (Qld) n (12) 93–4.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- Ensuring the quality\nand safety of protocols used by overseas gamete banks is also more difficult for local ART\nproviders, as is evident from the recently reported case of a mis-identified sperm donor.174\n172 For example, the risk of consanguineous relationships is higher in smaller jurisdictions: Sonia Allan, The\nReview of the Western Australian Human Reproductive Technology Act 1991 and the Surrogacy Act 2008:\nReport Part 1 (Report, January 2019) 119–28.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- They set out\nIt must always maintain excellence and credibility in equal goals across public health and safety, training\nregulating the higher risk professions and practitioners. standards and qualifications (including for overseas\nIt also needs inbuilt capability to grow and recalibrate, practitioners), workforce mobility, cultural safety, public\nso that it can meet new regulatory challenges and access to health services, and workforce development\nsupport health system and workforce priorities. and innovation.1 There are also guiding principles,\nwhich were added to the National Law in 2022.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- The assessment would include\nIn relation to the three reform options for entry to the not just recorded impacts and harms, but also aspects\nScheme that were presented in Recommendation such as lifelong harms and full consideration of broader\n8 of the Scope of Practice Review,9 the following risk factors.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- A broader suite of regulatory tools should be The Review noted with favour the manner in which the\nconsidered such as findings on breaches of Prohibition Orders are used in a wider fashion in NSW,\nstandards, cautions, warnings, education and where the Health Care Complaints Commission can\npractice conditions. issue a prohibition order against a relevant unlicensed\nand unaccredited private health organisation, where\nOffice of the Health Ombudsman (Queensland)\nan investigation shows that that organisation has\nThe commitment to completing implementation of breached the code of conduct relating to that\nthe Code of Conduct for Non-registered Practitioners organisation or been convicted of an offence under\nand then harmonising this across jurisdictions should public and private health or consumer and completion\noccur within the broader context of the proposed legislation.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- However, there are also practical and\nlegal dimensions to this approach that would\nMinisters have sought consideration of an additional\nneed to be fully examined, to avoid unintended\nMinisterial Power of Policy Direction for accreditation\nconsequences and to establish whether it would\nfunctions and progressing introduction of such a\nachieve the desired outcomes.\npower has been recommended in the Scope of\nPractice Review.16 • In the context of concerns about accreditation\ndecision making at specialist medical training sites,\nThe potential of this extended power is recognised.\nsteps to implement recommendation 13 from\nHowever, in the context of the complex dispersed\nthe NHPO inquiry (requiring a communications\narrangements for delivery of accreditation in the\nprotocol to ensure effective routine management of\nNational Scheme (as between the National Boards,\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- This follows the recommendations of\nimpacts if a college believes a training site is at risk\nthe National Health Practitioner Ombudsman (NHPO)\nof having its accreditation revoked).\ninquiry into accreditation in 2023.17 Many elements of\nthis are directed at addressing the concerns that gave The key question, not yet able to be answered,\nrise to the suggested consideration of a new Ministerial is whether current reform activity and/or potential\nPower of Policy Direction in this Review. legislative change arising from this NHPO accreditation\nreform work would obviate the need to introduce a\n• It is intended but not yet clear whether this work\nPower of Direction or have an impact on how such a\nwill deliver the effect of improving accountability\npower would need to be framed.\nand alignment with workforce objectives.\n• Further, Recommendation 23 of that report\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- There\n– A requirement that all decisions that would\nshould be clearer recourse for practitioners\nresult in extending the period that an\ninvestigation is open beyond 12 months be where there is potentially unnecessary\ndecisions of the Board, not regulatory officers.\ndelay in progressing matters to a tribunal,\n– An obligation on regulatory officers and the particularly where a practitioner has already\nBoards to consider the personal and financial\nbeen suspended through immediate\nimpacts on a practitioner in any decision to\naction powers.\nplace and investigation ‘on hold’.\n• Use the tagging and alert functions of the new\nThe Review was particularly struck by the strength of\nAhpra case management system to implement a\njudicial commentary on this specific issue in Peers v\nsystem for identifying, monitoring and reporting on Medical Board of Australia.27\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- It is also a requirement of the Code of Practice that all staff are authorised to perform the\nfunctions they have been employed to carry out,49 with specific qualification, training,\neducation and experience requirements for several key personnel, including professions that\nare not covered under the National Registration and Accreditation Scheme (NRAS) such as\nlaboratory managers, counsellors and quality managers.50 This includes a requirement for\nMedical and Clinical Directors to have a Certificate of Reproductive Endocrinology and\n42 Fertility Society of Australia and New Zealand, RTAC Scheme – Requirements for bodies providing audit and\ncertification to the Code of Practice for Assisted Reproductive Technology Units (20 December 2021) (‘RTAC\nScheme Rules’).\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- [pages 23,24]\ngh a corrective action plan at the next\naudit.\n• A major non-conformity is raised when an unmet Code requirement leads to an ineffective\noutcome with patient risk.\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n\n## Corporate Values and Operating Culture\n\n- [Page 23]\nFIGURE 1: STEWARDSHIP MODEL SUPPORTING THE NATIONAL SCHEME\nProtection of public\nHealth Health Workforce\nhealth and safety\nPractitioner Planning and\nand enabling\nRegulation workforce supply Strategy\nand service access\nSTATEMENT OF\nEXPECTATIONS\nSTATEMENT\nOF INTENT\nQUARTERLY\nPERFORMANCE\nPOLICY AND STRATEGY\nREPORTING\nADVICE AND EVIDENCE\nNational Scheme\nBoard\nScheme strategy\nand priorities\nLeading implementation\nof Scheme governance\nand stewardship reforms\nPartnership with\nNational Boards\nStronger collaboration\nwith Professions\nStrengthen accreditation\nin partnership with\naccreditation entities\nRelevant and timely\nexternal reporting\nCooperative Regulation\nAssuring Ahpra\ncapability and culture\nPro-active regulation\nADVICE\nincluding regulatory\nintelligence and\neducation awareness\nPIHSREBMEM\nYRATNEMELPPUS\nTHEME 1: SETTING STRATEGIC CONTEXT, PRIORITIES AND ACCOUNTABILITY FOR\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- ACTION 1.2 1.2.3 Disband the Jurisdictional Advisory Committee\nand its Jurisdictional Lead Officials Committee,\nConfirm the HWT as an ongoing Advisory\nto be replaced by a Health Practitioner\nCommittee to Health Ministers with the primary\nRegulation Committee of HWT.\nrole of advancing national workforce projects and\ninitiatives, including overseeing and contributing\nto processes for aligning workforce planning and ACTION 1.3\nhealth practitioner regulation, in collaboration\nHealth Chief Executives Forum (HCEF) to\nwith relevant professional bodies.\nconsider the option of a Strategy Assembly on\n1.2.1 Revise HWT Terms of Reference and Health Workforce and Practitioner Regulation\nrepresentation, to include: to be held every two years.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- The firm expectation should be that\ncurrent powers are used effectively that accreditation • The ‘4+2’ model worked well for rural and regional\nreforms are successfully progressed and augmented locations: it aligned with employer expectations,\nby strengthened oversight and collaboration measures accommodated a variety of service settings and\nthat are envisaged from this Review. connected provisionally registered psychologist\ninterns with employers, professional networks and\nIn terms of the effectiveness of current accreditation\nthe communities in which they lived and worked.\nreforms arising from the NHPO 2023 inquiry, oversight\nof this is within the remit of HWT.\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- For instance, the Review\nA more specific power of direction in relation to heard from health service providers the example of\nspecialist medical training college sites would therefore psychology standards pushing towards higher level\nbe required. post graduate clinical learning and away from clinical\nlearning at an undergraduate level, with significant\nFurthermore, consideration of the need for a new\nimpacts on the ability to attract and retain clinical\nMinisterial Power of Policy Direction should not\npsychologists in rural and regional areas during a time\nbe divorced from analysis and implementation of\nof increasing demand for mental healthcare services.\ncurrently available administrative and statutory tools\nThe issues and impacts were explained as follows:\nto strengthen the chain of accountability within\nthe Scheme. • The traditional ‘4+2’ training pathway to\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- Other complaints avenues\nUnder Australian Consumer Law, ART providers are required to comply with obligations\naround guarantees of service quality, prohibition of misleading or deceptive conduct, and\ncontracts and refunds.123 Consumers can file a complaint with their jurisdictional consumer\nprotection agency if they believe an ART provider has breached its statutory guarantees, such\nas failing to provide the service with due care and skill, or providing gametes that are not fit\nfor purpose.124 Additionally, the Therapeutic Goods Association can investigate complaints\nabout misleading or inappropriate advertising of therapeutic goods directed at consumers\n(including false or exaggerated health claims).125 The Australian Competition and Consumer\nCommission (ACCC) also takes reports from people about possible issues under consumer\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)`\n- [pages 23,24,25]\ng of\npolicy and strategy relevant national and\nWorkforce data\njurisdictional regulators\nProfessional\nMedical Workforce membership and Driving collaborative\nAdvisory Collaboration peak bodies regulation\nOversight of National Colleges and Gathering and analysing\nScheme Reforms Associations regulatory intelligence\nPolicy and Legislation Community Initial priorities:\nCommittee Representatives\n• Process for preparing\nHealth Practitioner Insurers and sharing\nRegulation Committee regulatory intelligence\nUnions\nNational Health • Information sharing\nComplaints Academics arrangements\nImplementation • Technology enabled\nCommittee regulation\n* Through project based consultation and inclusion and/or • Link to Ahpra\na Strategy Assembly convened at regular intervals\nmedicinal cannabis\ntaskforce\nADVICE\n21\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- The standards regulation – particularly to maintain\nkey requirements to be a high performing, risk-based strength in clinical advice, investigation and\nregulator can be identified across the two key domains prosecution capabilities and regulatory intelligence.\nof organisational and regulatory enablers, as follows.14\n• An embedded and enduring ethos of working in\ncollaboration with professions, peak bodies, State\nORGANISATIONAL ENABLERS\nand Territory jurisdictional health regulators and\n• Clear purpose and clarity of role other national health regulators.\n• Strategic and visible leadership, appropriate • Continuous improvement and a learning culture.\nsupporting structure and culture\n• Good internal governance\nAN IMMEDIATE STRATEGIC AGENDA\n• Accountability and transparency FOR THE NATIONAL SCHEME BOARD\n• Capable people\nThe Ministerial Council Statement of\n• ICT and data systems\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n- Scheme wide priorities 2025-26 — Built into the National Scheme Strategy 2025-30\n• Capability Review of Ahpra • Focus on accreditation • Reset National Board selection\naccountability reforms criteria and processes\n• Develop Scheme-wide performance\nmonitoring and reporting framework • Establish clear processes for • Strengthen stakeholder\nreview and approval of Codes engagement practices\n• Review budget and fee setting\nand Standards (including channels\nprocesses – transparent principles\nfor advice to Ministers)\nfor use of registrant funds\n64\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)`\n\n## Global Ideas and Case Study Inputs\n\n_No global-intelligence source text found yet. Run `CLAUDE/global-ideas-scraper.py <entity>` to populate case-study sources._\n\n## Source Artifacts Used\n\n- `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf` - strategies - https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf\n- `strategies/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-spec.pdf` - strategies - https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf\n- `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf` - reviews - https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf\n- `pages/about.html` - pages - https://www.health.gov.au/topics/about-the-department\n- `pages/announcements-index.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement\n- `pages/announcements-index__10.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement\n- `pages/announcements-index__11.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement?language=en\n- `pages/announcements-index__12.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety\n- `pages/announcements-index__13.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/regulator-statement\n- `pages/announcements-index__14.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/workplace-gender-equality-agency-employer-statement\n- `pages/homepage.html` - pages - https://www.health.gov.au/committees-and-groups/health-ministers-meeting-hmm#:~:text=The%20Health%20Ministers%20Meeting%20(HMM,Australian%20Government%20Minister%20for%20Health.\n- `pages/ministers.html` - pages - https://www.health.gov.au/committees-and-groups/health-ministers-meeting-hmm\n- `pages/news-latest.html` - pages - https://www.health.gov.au/news\n- `pages/priorities-index.html` - pages - https://www.health.gov.au/our-work\n- `pages/priorities-index__09.html` - pages - https://www.health.gov.au/our-work/aged-care-reforms?language=en\n- `pages/publications-index.html` - pages - https://www.health.gov.au/resources/publications/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia\n- `pages/reviews-index.html` - pages - https://www.health.gov.au/resources/publications/transforming-health-professionals-regulation-in-australia-independent-review-final-report\n- `pages/reviews-index__04.html` - pages - https://www.health.gov.au/resources/publications/transforming-health-professionals-regulation-in-australia-independent-review-final-report?language=en\n- `pages/reviews-index__05.html` - pages - https://www.health.gov.au/resources/publications/transforming-health-professionals-regulation-in-australia-independent-review-final-report\n- `pages/reviews-index__06.html` - pages - https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.docx\n- `pages/reviews-index__07.html` - pages - https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf\n- `pages/strategies-index.html` - pages - https://www.health.gov.au/resources/publications/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services\n- `pages/strategies-index__00.html` - pages - https://www.health.gov.au/resources/publications/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services?language=en\n- `pages/strategies-index__01.html` - pages - https://www.health.gov.au/resources/publications/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services\n- `pages/strategies-index__02.html` - pages - https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf\n- `pages/strategies-index__03.html` - pages - https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.docx\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf` - other-pdfs - https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf\n\n## Gaps To Fix\n\n- No corporate plan text source found.\n- No annual report text source found.\n- No global comparison/case-study sources found.",
  "legislation_md": "# Health Ministers' Meeting Forum - Acts and Legislation Discovery\n\n**Generated at**: 2026-05-09T21:24:55.880951+00:00\n**Entity ID**: B-004191\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n\n> This is an evidence-based discovery list from scraped department material. A mention does not always mean the department administers the legislation; high-confidence and official register links should be reviewed.\n\n## Summary\n\n- Source files scanned: 27\n- Unique legislation references found: 15\n\n| Type | Count |\n|---|---:|\n| Act | 13 |\n| Regulation | 2 |\n\n## Legislation References\n\n### Assisted Reproductive Technology Act 2024\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 6\n**Register search**: https://www.legislation.gov.au/search?query=Assisted+Reproductive+Technology+Act+2024\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- gulatory requirements that are imposed by State or Territory\nregulatory authorities.\nAccreditation of day procedure facilities against the NSQHC Standards is undertaken by\naccrediting agencies approved and overseen by the Commission. The Commission reviews\n70 Assisted Reproductive Technology Act 2024 (ACT) s 17.\n71 Assisted Reproductive Technology Act 2007 (NSW) s 6.\n72 Assisted Reproductive Technology Act 2024 (Qld) s 60.\n73 Assisted Reproductive Treatment Act 2008 (Vic) ss 74–81.\n74 Human Reproductive Technology Act (1991) (WA) s 27.\n75 This is with exc\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- re facilities against the NSQHC Standards is undertaken by\naccrediting agencies approved and overseen by the Commission. The Commission reviews\n70 Assisted Reproductive Technology Act 2024 (ACT) s 17.\n71 Assisted Reproductive Technology Act 2007 (NSW) s 6.\n72 Assisted Reproductive Technology Act 2024 (Qld) s 60.\n73 Assisted Reproductive Treatment Act 2008 (Vic) ss 74–81.\n74 Human Reproductive Technology Act (1991) (WA) s 27.\n75 This is with exception to South Australia, which do not have a specified registration period in their ART\nlegislation. SA’s healt\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- or territory regulators.\nTable 2.6: Adverse event reporting requirements by jurisdiction.\nACT NSW NT QLD SA TAS VIC WA\nJurisdictional\nadverse event\n# ~^ ~*\nreporting\nrequirements\n#The Australian Capital Territory is yet to complete regulations to support the Assisted Reproductive Technology\nAct 2024 (ACT), which may include prescribing other events that must be reported to the Australian Capital Territory\nHealth and Community Services Directorate.\n^Queensland will require mandatory adverse event reporting from 1 March 2026.\n*Tasmania requires reporting o\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- e service provider directly. This is consistent with complaints handling\nprocesses across health care more widely. If a complaint is not adequately resolved with the\nART unit or by the individual provider, then RTAC recommends that the complainant contact\n108 The Assisted Reproductive Technology Act 2024 (ACT) includes scalable enforcement options in the event of\nlegislative non-compliance by providers, including: improvement notices, prohibition notices, enforceable\nundertakings, information or document production notices and infringement notices.\n109 The As\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- y\nclinics must ensure the number of “families” born from a single donor is limited to five. Whereas in New South Wales,\na donated gamete cannot be used for ART treatment in more than five families, with reference to the number of\n“women” rather than families: Assisted Reproductive Technology Act 2024 (ACT) s 40; Assisted Reproductive\nTechnology Act 2007 (NSW) s 27.\nPage 58\n\n[page 59]\n5 System improvement\n“Every system is perfectly designed to get the results it gets”\nW Edwards Deming\nAs we outlined in chapter 1, Health Ministers instructed the Health Chie\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Assisted Reproductive Technology Act 2007\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 4\n**Register search**: https://www.legislation.gov.au/search?query=Assisted+Reproductive+Technology+Act+2007\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- ory\nregulatory authorities.\nAccreditation of day procedure facilities against the NSQHC Standards is undertaken by\naccrediting agencies approved and overseen by the Commission. The Commission reviews\n70 Assisted Reproductive Technology Act 2024 (ACT) s 17.\n71 Assisted Reproductive Technology Act 2007 (NSW) s 6.\n72 Assisted Reproductive Technology Act 2024 (Qld) s 60.\n73 Assisted Reproductive Treatment Act 2008 (Vic) ss 74–81.\n74 Human Reproductive Technology Act (1991) (WA) s 27.\n75 This is with exception to South Australia, which do not have a specified\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- ofessional standards and any conditions or restrictions placed on registration.\nAhpra can receive complaints and notifications of conduct alleged to breach professional\nstandards and undertake investigations. Anyone can make a notification to Ahpra or the\n104 Assisted Reproductive Technology Act 2007 (NSW) s 27(1A).\nPage 29\n\n[page 30]\nrelevant National Board if they believe a registered health professional has breached\nstandards of professional conduct.\nFor each notification that is accepted, Ahpra will first assess the notification, which determines\nthe\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- Zealand, RTAC Code of Practice (n 38) s 2.6.\n114 Fertility Society of Australia and New Zealand, RTAC Code of Practice (n 38) s 2.6.\n115 Fertility Society of Australia and New Zealand, RTAC Scheme Rules (n 42) s 4.1.2.1b.\n116 If a complaint is in scope of the Assisted Reproductive Technology Act 2007 (NSW) or Assisted Reproductive\nTechnology Regulation 2024 (NSW), the Ministry for Health will manage it in accordance with its legislative\npowers. If it is outside the scope of the NSW legislation, it may refer the complainant to the NSW Health Care\nComplaint\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- om a single donor is limited to five. Whereas in New South Wales,\na donated gamete cannot be used for ART treatment in more than five families, with reference to the number of\n“women” rather than families: Assisted Reproductive Technology Act 2024 (ACT) s 40; Assisted Reproductive\nTechnology Act 2007 (NSW) s 27.\nPage 58\n\n[page 59]\n5 System improvement\n“Every system is perfectly designed to get the results it gets”\nW Edwards Deming\nAs we outlined in chapter 1, Health Ministers instructed the Health Chief Executives to\ncommission a rapid review of the accre\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Assisted Reproductive Treatment Act 1988\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 3\n**Register search**: https://www.legislation.gov.au/search?query=Assisted+Reproductive+Treatment+Act+1988\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- ory scheme for the safety and quality of\nthe sector.\nPage 27\n\n[page 28]\nTable 2.5: Investigatory powers by jurisdiction.\nACT NSW NT QLD SA TAS VIC WA\nPower to\nundertake ~*\ninvestigations\n*South Australia does not have express powers of investigation under the Assisted Reproductive Treatment Act\n1988 (SA) and are limited to undertake investigations into a registered clinic using powers of an Authorised Person\nor relying on conditions of their registration which state they must provide specified information as requested to the\nMinister.\nAdverse event repor\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- 2018 Vic Interim Report of the Independent Review of Assisted\nReproductive Treatment.\n2019 WA The Review of the Western Australian Human Reproductive\nTechnology Act 1991 and the Surrogacy Act 2008 (Report:\nPart 1).\nJanuary 2017 SA Report on the review of the Assisted Reproductive Treatment\nAct 1988 (SA).\nMay 2014 NSW Report on the Statutory Review of the Assisted Reproductive\nTechnology Act 2007 (NSW)\nFebruary 2014 WA Position on the Posthumous Collection and Use of Gametes.\nPage 78\n\n[page 79]\nAppendix 2\nTable A2: Summary of State and Territory regulato\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- Queensland legislation will not come into effect until March 2026.\n# The number of conditions applied in Victoria may not represent all conditions applied due to changes in reporting.\n## South Australia does not have express powers of investigation under the Assisted Reproductive Treatment Act 1988 (SA) and are limited to undertake investigations into a\nregistered clinic using powers of an Authorised Person or relying on conditions of their registration which state they must provide specified information as requested to the Minister.\n~ The Australian Ca\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Health Practitioners Competence Assurance Act 2003\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Health+Practitioners+Competence+Assurance+Act+2003\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- mbryologists have usually completed a postgraduate-\nlevel work-based training program.197 Once registered, clinical embryologists must undertake\nCPD to keep their knowledge and skills up to date.\nIn New Zealand, embryologists are currently regulated under the Health Practitioners\nCompetence Assurance Act 2003 falling under the broader category of medical laboratory\nscientists which is a regulated profession overseen by the Medical Sciences Council of New\nZealand (MSCNZ).198 To be registered under the MSCNZ, embryologists much obtain their\nqualification from an acc\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- //www.hcpc-\nuk.org/about-us/who-we-regulate/the-professions/>.\n197 ‘How to become clinical scientist in embryology’, NHS Scotland Careers (Web Page, 2023)\n<https://www.careers.nhs.scot/explore-careers/healthcare-science/clinical-scientist-in-embryology/>.\n198 Health Practitioners Competence Assurance Act 2003 (NZ) sch 2; New Zealand, Notice of Scopes of Practice\nand Prescribed Qualifications for the Practice of Medical Laboratory Science, No 2021-gs2023, 1 June 2021.\nPage 65\n\n[page 66]\n5.2 Regulation reform opportunities\nWe identified three improvement opportuniti\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Health Care Complaints Act 1983\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Health+Care+Complaints+Act+1983\n\n**Sources**:\n- `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pages.jsonl`\n\n**Evidence contexts**:\n- tory practice since the independent review\nAvailable at: https://www.ahpra.gov.au/Search. of the use of chaperones to protect patients in\naspx?q=AHMAC%20criteria%201995. Australia, p27. Available at: https://www.ahpra.\ngov.au/documents/default.aspx?record=\n13 Health Care Complaints Act 1983 (NSW),\nWD20%2f30454&dbid=AP&chksum=\nDivision 7A.\nYE1XW9tLtpZFD7LUE0lGGg%3d%3d.\n14 See for instance Tune, D (2023) Report of the\n20 Ahpra (2024). Annual Report 2023-2024,\nIndependent Capability Review of the Aged\nPage 69, Available at: https://www.ahpra.\nCare\n  Source: `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pages.jsonl`\n\n### Health Service Establishments Regulations 2021\n\n**Type**: Regulation\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Health+Service+Establishments+Regulations+2021\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- tain a registry of donors to enable tracking of genetic history for donor\nconceived people to access (see Table 2.7). There are mandatory registers and voluntary\nregisters, with different operating models in place across the country. Consumer stakeholders\n103 Health Service Establishments Regulations 2021 (Tas) Schedule 1, Part 4, Clause 10.\nPage 28\n\n[page 29]\nraised significant concerns about access to donor information when it is held by IVF providers\n(section 4.5).\nTable 2.7: Donor registries by jurisdiction.\nACT NSW NT QLD SA TAS VIC WA\nDonor registry\nTher\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### National Health Reform Act 2011\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=National+Health+Reform+Act+2011\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- ission on Safety and Quality in Health Care (the Commission) is\nresponsible for overseeing the accreditation of healthcare facilities including health services;\npublic, private and day hospitals; and cosmetic surgery clinics. The Commission is governed\nby the National Health Reform Act 2011 (Cth) and is accountable to the Australian parliament\nthrough the Commonwealth Minister for Health, Disability and Ageing. It is funded jointly by\nthe Australian Government and State and Territory governments.\nThe Commission develops and maintains the Nationa\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Assisted Reproductive Treatment Act 2008\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Assisted+Reproductive+Treatment+Act+2008\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- y\naccrediting agencies approved and overseen by the Commission. The Commission reviews\n70 Assisted Reproductive Technology Act 2024 (ACT) s 17.\n71 Assisted Reproductive Technology Act 2007 (NSW) s 6.\n72 Assisted Reproductive Technology Act 2024 (Qld) s 60.\n73 Assisted Reproductive Treatment Act 2008 (Vic) ss 74–81.\n74 Human Reproductive Technology Act (1991) (WA) s 27.\n75 This is with exception to South Australia, which do not have a specified registration period in their ART\nlegislation. SA’s health department advised registration period for ART units i\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n- event of legislative\nnon-compliance by providers, including: improvement notice, prohibition notices – applying to ART services of a\nstated kind, or all ART services, imposing and varying licence conditions, cancelling a licence and suspending a\nlicence.\n110 The Assisted Reproductive Treatment Act 2008 (Vic) include scalable enforcement options in the event of\nlegislative non-compliance by providers, including: require provider to appoint an external auditor, notice to\ncompel production of information or documents, power to enter premises to conduct an insp\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Assisted Reproductive Act 2024\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Assisted+Reproductive+Act+2024\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- t 2024 (ACT) includes scalable enforcement options in the event of\nlegislative non-compliance by providers, including: improvement notices, prohibition notices, enforceable\nundertakings, information or document production notices and infringement notices.\n109 The Assisted Reproductive Act 2024 (Qld) provides scalable enforcement options in the event of legislative\nnon-compliance by providers, including: improvement notice, prohibition notices – applying to ART services of a\nstated kind, or all ART services, imposing and varying licence conditions,\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Assisted Reproductive Technology Regulation 2024\n\n**Type**: Regulation\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Assisted+Reproductive+Technology+Regulation+2024\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- rtility Society of Australia and New Zealand, RTAC Code of Practice (n 38) s 2.6.\n115 Fertility Society of Australia and New Zealand, RTAC Scheme Rules (n 42) s 4.1.2.1b.\n116 If a complaint is in scope of the Assisted Reproductive Technology Act 2007 (NSW) or Assisted Reproductive\nTechnology Regulation 2024 (NSW), the Ministry for Health will manage it in accordance with its legislative\npowers. If it is outside the scope of the NSW legislation, it may refer the complainant to the NSW Health Care\nComplaints Commission.\n117 ‘Information for people making complaint\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Competition and Consumer Act 2010\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Competition+and+Consumer+Act+2010\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- ted health claims).125 The Australian Competition and Consumer\nCommission (ACCC) also takes reports from people about possible issues under consumer\nlaw about false or misleading claims, but does not resolve individual disputes about misleading\nclaims.126\n123 Competition and Consumer Act 2010 (Cth) sch 2 ss 18, 29, 60–62, 64, 67.\n124 ‘Consumer Protection Agencies’, Australian Government (Web Page)\n<https://consumer.gov.au/consumers/consumer-protection-agencies>.\n125 ‘Report’, Therapeutic Goods Administration Care (Web Page) <https://compliance.hea\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### NSW Report on the Statutory Review of the Assisted Reproductive Technology Act 2007\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=NSW+Report+on+the+Statutory+Review+of+the+Assisted+Reproductive+Technology+Act+2007\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- sisted\nReproductive Treatment.\n2019 WA The Review of the Western Australian Human Reproductive\nTechnology Act 1991 and the Surrogacy Act 2008 (Report:\nPart 1).\nJanuary 2017 SA Report on the review of the Assisted Reproductive Treatment\nAct 1988 (SA).\nMay 2014 NSW Report on the Statutory Review of the Assisted Reproductive\nTechnology Act 2007 (NSW)\nFebruary 2014 WA Position on the Posthumous Collection and Use of Gametes.\nPage 78\n\n[page 79]\nAppendix 2\nTable A2: Summary of State and Territory regulatory powers and jurisdictional features (Tables 2.1 – 2.8).\nACT NSW NT QLD SA TAS Vic WA\nRegistration\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Research Involving Human Embryos Act 2002\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Research+Involving+Human+Embryos+Act+2002\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- n organisation meets the requirements of governing industry standards.\nProviders must be accredited by RTAC to operate in the sector\nMost states and territories require a new ART unit to obtain RTAC accreditation prior to\ncommencing provision of ART services. The Research Involving Human Embryos Act 2002\n(Cth) also prescribes that all new ART units must obtain initial RTAC accreditation.\nAs summarised above, RTAC accreditation involves the ART unit undergoing a primary audit\nby one of the two approved accreditation agencies (certifying bodies). The primary au\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### Sonia Allan, The Review of the Western Australian Human Reproductive Technology Act 1991\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Sonia+Allan%2C+The+Review+of+the+Western+Australian+Human+Reproductive+Technology+Act+1991\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- ocols used by overseas gamete banks is also more difficult for local ART\nproviders, as is evident from the recently reported case of a mis-identified sperm donor.174\n172 For example, the risk of consanguineous relationships is higher in smaller jurisdictions: Sonia Allan, The\nReview of the Western Australian Human Reproductive Technology Act 1991 and the Surrogacy Act 2008:\nReport Part 1 (Report, January 2019) 119–28.\n173 Gorton (n 12) 118.\n174 Grace Tobin and Kirsten Robb, ‘IVF Clinic Queensland Fertility Group Silenced White Couple Who Gave Birth\nTo Biracial Baby In Sperm Mix-up’, ABC News (online,\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n### WA The Review of the Western Australian Human Reproductive Technology Act 1991\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=WA+The+Review+of+the+Western+Australian+Human+Reproductive+Technology+Act+1991\n\n**Sources**:\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n**Evidence contexts**:\n- nto Assisted Reproductive Treatment Practices in\nVictoria: Final Report.\nMay 2019 Vic Final Report of the Independent Review of Assisted\nReproductive Treatment.\nOctober 2018 Vic Interim Report of the Independent Review of Assisted\nReproductive Treatment.\n2019 WA The Review of the Western Australian Human Reproductive\nTechnology Act 1991 and the Surrogacy Act 2008 (Report:\nPart 1).\nJanuary 2017 SA Report on the review of the Assisted Reproductive Treatment\nAct 1988 (SA).\nMay 2014 NSW Report on the Statutory Review of the Assisted Reproductive\nTechnology Act 2007 (NSW)\nFebruary 2014 WA Positio\n  Source: `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl`\n\n## Files Scanned\n\n- `pages/about.html` (page)\n- `pages/announcements-index.html` (page)\n- `pages/announcements-index__10.html` (page)\n- `pages/announcements-index__11.html` (page)\n- `pages/announcements-index__12.html` (page)\n- `pages/announcements-index__13.html` (page)\n- `pages/announcements-index__14.html` (page)\n- `pages/homepage.html` (page)\n- `pages/ministers.html` (page)\n- `pages/news-latest.html` (page)\n- `pages/priorities-index.html` (page)\n- `pages/priorities-index__09.html` (page)\n- `pages/publications-index.html` (page)\n- `pages/reviews-index.html` (page)\n- `pages/reviews-index__04.html` (page)\n- `pages/reviews-index__05.html` (page)\n- `pages/reviews-index__06.html` (page)\n- `pages/reviews-index__07.html` (page)\n- `pages/strategies-index.html` (page)\n- `pages/strategies-index__00.html` (page)\n- `pages/strategies-index__01.html` (page)\n- `pages/strategies-index__02.html` (page)\n- `pages/strategies-index__03.html` (page)\n- `other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pages.jsonl` (pdf_pages)\n- `reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pages.jsonl` (pdf_pages)\n- `strategies/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-spec.pages.jsonl` (pdf_pages)\n- `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pages.jsonl` (pdf_pages)",
  "global_initiatives_md": null,
  "strategy": {
    "reporting_period": "2024-25",
    "corporate_plan_period": "2025-26",
    "vision": null,
    "vision_source_page": null,
    "purposes": null,
    "purposes_source_page": null,
    "how_we_deliver": null,
    "how_we_deliver_source_page": null,
    "government_priorities": [],
    "outcomes": [],
    "values": [],
    "values_framework_name": null,
    "kpi_targets_2025_26": [],
    "kpi_results_2024_25": [],
    "_source_urls": {
      "annual_report_url": "",
      "corporate_plan_url": ""
    }
  },
  "ideas": [
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Regulation & Policy",
      "scale": "small",
      "title": "Regulatory burden scan for forms, guidance, and reporting",
      "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.",
      "quote": "[pages 23,24,25]\ng of\npolicy and strategy relevant national and\nWorkforce data\njurisdictional regulators\nProfessional\nMedical Workforce membership and Driving collaborative\nAdvisory Collaboration peak bodies regulation\nOversight of National Colleges and Gathering and analysing\nScheme Reforms Associations regulatory intelligence\nPolicy and Legislation Community Initial priorities:\nCommittee Representatives\n• Process for preparing\nHealth Practitioner Insurers and sharing\nRegulation Committee regulatory intelligence\nUnions\nNational Health • Information sharing\nComplaints Academics arrangements\nImplementation • Technology enabled\nCommittee regulation\n* Through project based consultation and inclusion and/or • Link to Ahpra\na Strategy Assembly convened at regular intervals\nmedicinal cannabis\ntaskforce\nADVICE\n21",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Regulated entities / policy teams",
      "source": "reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Regulation & Policy",
      "scale": "large",
      "title": "Adaptive regulation program with live feedback loops",
      "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.",
      "quote": "[pages 23,24,25]\ng of\npolicy and strategy relevant national and\nWorkforce data\njurisdictional regulators\nProfessional\nMedical Workforce membership and Driving collaborative\nAdvisory Collaboration peak bodies regulation\nOversight of National Colleges and Gathering and analysing\nScheme Reforms Associations regulatory intelligence\nPolicy and Legislation Community Initial priorities:\nCommittee Representatives\n• Process for preparing\nHealth Practitioner Insurers and sharing\nRegulation Committee regulatory intelligence\nUnions\nNational Health • Information sharing\nComplaints Academics arrangements\nImplementation • Technology enabled\nCommittee regulation\n* Through project based consultation and inclusion and/or • Link to Ahpra\na Strategy Assembly convened at regular intervals\nmedicinal cannabis\ntaskforce\nADVICE\n21",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Regulated entities / policy teams",
      "source": "reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Staff Productivity",
      "scale": "small",
      "title": "Reusable briefing and summary assistant for internal documents",
      "idea": "Create controlled templates for summarising reports, submissions, minutes, and ministerial briefs.",
      "quote": "[Page 23]\nFIGURE 1: STEWARDSHIP MODEL SUPPORTING THE NATIONAL SCHEME\nProtection of public\nHealth Health Workforce\nhealth and safety\nPractitioner Planning and\nand enabling\nRegulation workforce supply Strategy\nand service access\nSTATEMENT OF\nEXPECTATIONS\nSTATEMENT\nOF INTENT\nQUARTERLY\nPERFORMANCE\nPOLICY AND STRATEGY\nREPORTING\nADVICE AND EVIDENCE\nNational Scheme\nBoard\nScheme strategy\nand priorities\nLeading implementation\nof Scheme governance\nand stewardship reforms\nPartnership with\nNational Boards\nStronger collaboration\nwith Professions\nStrengthen accreditation\nin partnership with\naccreditation entities\nRelevant and timely\nexternal reporting\nCooperative Regulation\nAssuring Ahpra\ncapability and culture\nPro-active regulation\nADVICE\nincluding regulatory\nintelligence and\neducation awareness\nPIHSREBMEM\nYRATNEMELPPUS\nTHEME 1: SETTING STRATEGIC CONTEXT, PRIORITIES AND ACCOUNTABILITY FOR",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "APS staff / executives",
      "source": "reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Sensitive information leakage",
        "Inconsistent quality of generated drafts"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Staff Productivity",
      "scale": "large",
      "title": "Department-wide knowledge and briefing platform",
      "idea": "Build a secure knowledge platform that lets staff search, summarise, and cite approved departmental material.",
      "quote": "[Page 23]\nFIGURE 1: STEWARDSHIP MODEL SUPPORTING THE NATIONAL SCHEME\nProtection of public\nHealth Health Workforce\nhealth and safety\nPractitioner Planning and\nand enabling\nRegulation workforce supply Strategy\nand service access\nSTATEMENT OF\nEXPECTATIONS\nSTATEMENT\nOF INTENT\nQUARTERLY\nPERFORMANCE\nPOLICY AND STRATEGY\nREPORTING\nADVICE AND EVIDENCE\nNational Scheme\nBoard\nScheme strategy\nand priorities\nLeading implementation\nof Scheme governance\nand stewardship reforms\nPartnership with\nNational Boards\nStronger collaboration\nwith Professions\nStrengthen accreditation\nin partnership with\naccreditation entities\nRelevant and timely\nexternal reporting\nCooperative Regulation\nAssuring Ahpra\ncapability and culture\nPro-active regulation\nADVICE\nincluding regulatory\nintelligence and\neducation awareness\nPIHSREBMEM\nYRATNEMELPPUS\nTHEME 1: SETTING STRATEGIC CONTEXT, PRIORITIES AND ACCOUNTABILITY FOR",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "APS staff / executives",
      "source": "reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Sensitive information leakage",
        "Inconsistent quality of generated drafts"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Risk & Assurance",
      "scale": "small",
      "title": "Recommendation tracker for audits, reviews, and inquiries",
      "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.",
      "quote": "During the 2024-25 financial year, we acted to further strengthen our compliance with the\nCommonwealth Child Safe Framework\nand to minimise key risks, including:\nreviewing and updating the Department's Child Safety Policy, with additional guidance about risk management and working with children check requirements for all Australian jurisdictions\nproviding additional guidance information about child safety risks for departmental staff undertaking annual risk assessment processes\nmaturity self-assessment to identify areas for improvement aligned to annual risk assessment processes\nOur divisional business and risk planning process includes an annual risk assessment regarding the level of direct or indirect contact with children across our department.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / assurance teams",
      "source": "pages/announcements-index__12.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Risk & Assurance",
      "scale": "large",
      "title": "Integrated assurance and lessons-learned system",
      "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.",
      "quote": "During the 2024-25 financial year, we acted to further strengthen our compliance with the\nCommonwealth Child Safe Framework\nand to minimise key risks, including:\nreviewing and updating the Department's Child Safety Policy, with additional guidance about risk management and working with children check requirements for all Australian jurisdictions\nproviding additional guidance information about child safety risks for departmental staff undertaking annual risk assessment processes\nmaturity self-assessment to identify areas for improvement aligned to annual risk assessment processes\nOur divisional business and risk planning process includes an annual risk assessment regarding the level of direct or indirect contact with children across our department.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / assurance teams",
      "source": "pages/announcements-index__12.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Citizen Services",
      "scale": "small",
      "title": "Plain-language service pages and proactive status updates",
      "idea": "Rewrite high-volume pages and letters into plain language, add status notifications, and measure contact reduction.",
      "quote": "In 2023, 81% of ART cycles were provided\nto male-female couples, 14.6% were to single women, and 4.4% were to female-female\ncouples.9 For oocyte and embryo recipient cycles, almost 40% were provided to single women\nor female-female couples, indicating growing inclusivity in access to fertility services.10 This is\nalso reflected in a growing demand for donor gametes that exceeds supply.11 This has resulted\nin increased importation of gametes from international gamete banks and the increased use\nof informal channels by consumers for gamete donations.12\nART services are predominantly delivered by private providers\nThe number of ART providers and ART clinics in Australia continues to grow.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Citizens / service users",
      "source": "other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Digital exclusion",
        "Low public trust if feedback is not acted on"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Citizen Services",
      "scale": "large",
      "title": "Single front door for life-event based services",
      "idea": "Bundle services around life events so citizens can complete related steps across agencies in one journey.",
      "quote": "In 2023, 81% of ART cycles were provided\nto male-female couples, 14.6% were to single women, and 4.4% were to female-female\ncouples.9 For oocyte and embryo recipient cycles, almost 40% were provided to single women\nor female-female couples, indicating growing inclusivity in access to fertility services.10 This is\nalso reflected in a growing demand for donor gametes that exceeds supply.11 This has resulted\nin increased importation of gametes from international gamete banks and the increased use\nof informal channels by consumers for gamete donations.12\nART services are predominantly delivered by private providers\nThe number of ART providers and ART clinics in Australia continues to grow.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Citizens / service users",
      "source": "other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Digital exclusion",
        "Low public trust if feedback is not acted on"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Data & Performance",
      "scale": "small",
      "title": "KPI evidence register with named owners",
      "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.",
      "quote": "It provides regular\nperformance benchmarking and feedback to ART units and RTAC.91 All ART units are required\nto provide de-identified patient and treatment information to ANZARD on IVF cycles, donor\ninsemination cycles, pregnancy and birth outcomes as well as demographic details including\nsex, age, and infertility diagnosis.92\nThese data are used to inform benchmarking of each ART unit against the publicly available\nannual ANZARD Report.93 If clinical outcomes (e.g. pregnancy rates) fall below the 25th\npercentile in an age group the ART unit must undertake a root cause analysis and address\nany issues during the audit process.94 If clinical outcomes fall below three standard\ndeviations,95 the RTAC Chair will notify the unit.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / Parliament / public",
      "source": "other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Data & Performance",
      "scale": "large",
      "title": "Outcome dashboard linking budget, delivery, and public impact",
      "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.",
      "quote": "It provides regular\nperformance benchmarking and feedback to ART units and RTAC.91 All ART units are required\nto provide de-identified patient and treatment information to ANZARD on IVF cycles, donor\ninsemination cycles, pregnancy and birth outcomes as well as demographic details including\nsex, age, and infertility diagnosis.92\nThese data are used to inform benchmarking of each ART unit against the publicly available\nannual ANZARD Report.93 If clinical outcomes (e.g. pregnancy rates) fall below the 25th\npercentile in an age group the ART unit must undertake a root cause analysis and address\nany issues during the audit process.94 If clinical outcomes fall below three standard\ndeviations,95 the RTAC Chair will notify the unit.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / Parliament / public",
      "source": "other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf (https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Citizen Participation",
      "scale": "small",
      "title": "Consultation feedback summaries with response tracking",
      "idea": "Summarise consultation submissions by theme and publish what changed in response.",
      "quote": "[Page 15]\nEXECUTIVE SUMMARY\nBENEFITS TO STAKEHOLDERS\nREGISTERED PROFESSIONS, COLLEGES\nAND PRACTITIONERS\nHEALTH CONSUMERS AND • Stronger focus on professions input to\nTHE COMMUNITY workforce strategy and regulatory policy.\n• Reducing delays in investigations and\n• There will be a clear picture of how all health\nprosecutions, minimising practitioners distress.\nprofessions are regulated in Australia.\n• A unified model for complaints to ensure\n• The community will have a stronger voice to\nimproved management and so that lower level\ninform the National Scheme.\nmatters are not handled by Ahpra.\n• Consumer will have confidence and trust in the\n• Fee setting and budget processes will\nquality of health services in Australia.\nbecome more transparent.\n• New risks to public health and safety will be\n• Improved sustainability of the Scheme.\naddressed more proactively and effectively.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Citizens / stakeholders / policy teams",
      "source": "reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Digital exclusion",
        "Low public trust if feedback is not acted on"
      ]
    },
    {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "category": "Citizen Participation",
      "scale": "large",
      "title": "Always-on policy participation platform",
      "idea": "Create a standing participation platform where citizens and stakeholders can propose, vote, and track ideas.",
      "quote": "[Page 15]\nEXECUTIVE SUMMARY\nBENEFITS TO STAKEHOLDERS\nREGISTERED PROFESSIONS, COLLEGES\nAND PRACTITIONERS\nHEALTH CONSUMERS AND • Stronger focus on professions input to\nTHE COMMUNITY workforce strategy and regulatory policy.\n• Reducing delays in investigations and\n• There will be a clear picture of how all health\nprosecutions, minimising practitioners distress.\nprofessions are regulated in Australia.\n• A unified model for complaints to ensure\n• The community will have a stronger voice to\nimproved management and so that lower level\ninform the National Scheme.\nmatters are not handled by Ahpra.\n• Consumer will have confidence and trust in the\n• Fee setting and budget processes will\nquality of health services in Australia.\nbecome more transparent.\n• New risks to public health and safety will be\n• Improved sustainability of the Scheme.\naddressed more proactively and effectively.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Citizens / stakeholders / policy teams",
      "source": "reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf (https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Digital exclusion",
        "Low public trust if feedback is not acted on"
      ]
    }
  ],
  "legislation_administered": [],
  "artifacts": [
    {
      "category": "strategies",
      "year": "2024",
      "url": "https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf",
      "file": "strategies/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-spec.pdf",
      "bytes": 1207924,
      "link_text": "Framework for the assessment, funding and implementation of high cost, highly specialised therapies and services [PDF - 2 MB] - 19 pages"
    },
    {
      "category": "strategies",
      "year": "2024",
      "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf",
      "file": "strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf",
      "bytes": 289017,
      "link_text": "Standard for AI transparency statements"
    },
    {
      "category": "reviews",
      "year": "2025",
      "url": "https://www.health.gov.au/sites/default/files/2025-09/transforming-health-professionals-regulation-in-australia-independent-review-final-report.pdf",
      "file": "reviews/transforming-health-professionals-regulation-in-australia-independent-review-fin.pdf",
      "bytes": 6944718,
      "link_text": "Transforming health professionals regulation in Australia: Independent Review Final Report [PDF - 7 MB] - 96 pages"
    },
    {
      "category": "other-pdfs",
      "year": "2025",
      "url": "https://www.health.gov.au/sites/default/files/2025-09/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regulation-and-accreditation-in-australia.pdf",
      "file": "other-pdfs/rapid-review-of-assisted-reproductive-technology-and-in-vitro-fertilisation-regu.pdf",
      "bytes": 1277794,
      "link_text": "Rapid Review of Assisted Reproductive Technology and In Vitro Fertilisation Regulation and Accreditation in Australia [PDF - 2 MB]"
    }
  ],
  "_meta": {
    "snapshot_built_at": "2026-05-13T11:02:51+00:00",
    "strategy_brief_meta": {
      "model": "nova-micro",
      "folder": "Health-Ministers-Meeting-Forum",
      "annual_report": {
        "file": null,
        "url": "",
        "year": null
      },
      "corporate_plan": {
        "file": "strategies\\framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-spec.txt",
        "url": "https://www.health.gov.au/sites/default/files/2024-04/framework-for-the-assessment-funding-and-implementation-of-high-cost-highly-specialised-therapies-and-services.pdf",
        "year": null
      },
      "usage": {
        "input_tokens": 8098,
        "output_tokens": 155,
        "total_tokens": 8253,
        "model": "nova-micro"
      },
      "cost_usd": 0.00030513,
      "elapsed_seconds": 19.71,
      "generated_at": "2026-05-13T05:17:22+00:00"
    },
    "ideas_manifest": {
      "entity_id": "B-004191",
      "entity_name": "Health Ministers' Meeting Forum",
      "folder_name": "Health-Ministers-Meeting-Forum",
      "generated_at": "2026-05-09T23:06:01.913032+00:00",
      "idea_count": 12,
      "markdown": "ideas/Health-Ministers-Meeting-Forum_ideas.md",
      "jsonl": "ideas/ideas.jsonl",
      "inputs": [
        "Health-Ministers-Meeting-Forum_strategy-overview.md",
        "strategy-evidence.json",
        "global-intelligence/source-manifest.json"
      ]
    },
    "global_intel_meta": null
  }
}